JPMorgan Reiterates Neutral Rating on Medtronic, Inc. (MDT) Ahead of Earnings
Tweet Send to a Friend
JPMorgan analyst Robbie Marcus reiterated a Neutral rating and $95.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst comments "Medtronic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
